CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Open-market sale SVP, Chief Financial Officer sold 35,000 shares at an average $20.00 ($699,918)
- 4 Open-market sale EVP R&D, Chief Medical Officer sold 28,920 shares at $19.72 ($570,288)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,292 shares (to pay taxes)
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 14,386 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 4,947 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 2,786 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 5,086 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CLO, Alkermes, Inc. gave up 4,083 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,790 shares (to pay taxes)
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 11,943 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 3,170 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 1,606 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 1,172 shares (to pay taxes)
Page 18 of 67 · 1,323 filings